Neoplasm of Uncertain Histogenesis — Trials

Neoplasm of Uncertain Histogenesis — Trials · CancerIndex

Clinical trials

Registered studies

91,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 601–650 of 2,540 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03503409	IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome	active not recruiting	Phase 2	68	Groupe Francophone des MyelodysplasiesOTHER	2	Aug 10, 2026	clinicaltrials
NCT03744390	IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome	active not recruiting	Phase 2	68	Groupe Francophone des MyelodysplasiesOTHER	1	Aug 10, 2026	clinicaltrials